All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
|
|
|
|
|
QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
ZNTL / Zentalis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PGNY / Progyny, Inc.
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
OM / Outset Medical, Inc.
|
|
|
|
|
|
|
|
SILK / Silk Road Medical, Inc
|
|
|
|
|
|
|
|
VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
ETRN / Equitrans Midstream Corporation
|
|
|
|
|
|
|
|
CABA / Cabaletta Bio, Inc.
|
|
|
|
|
|
|
|
CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
ALMS / Alumis Inc.
|
|
|
|
|
|
|
|
OVV / Ovintiv Inc.
|
|
|
|
|
|
|
|
IFRX / InflaRx N.V.
|
|
|
|
|
|
|
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TSVT / 2seventy bio, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
ATEC / Alphatec Holdings, Inc.
|
|
|
|
|
|
|
|
GTHX / G1 Therapeutics, Inc.
|
|
|
|
|
|
|
|
FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
LQDA / Liquidia Corporation
|
|
|
|
|
|
|
|
AXGN / Axogen, Inc.
|
|
|
|
|
|
|
|
BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
BDSX / Biodesix, Inc.
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
ELUT / Elutia Inc.
|
|
|
|
|
|
|
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
|
|
|
|
|
HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
TXG / 10x Genomics, Inc.
|
|
|
|
|
|
|
|
WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
KROS / Keros Therapeutics, Inc.
|
|
|
|
|
|
|
|
PHR / Phreesia, Inc.
|
|
|
|
|
|
|
|
CGEM / Cullinan Therapeutics, Inc.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
HROW / Harrow, Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
CORT / Corcept Therapeutics Incorporated
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
XOM / Exxon Mobil Corporation
|
|
|
|
|
|
|
|
AXDX / Accelerate Diagnostics, Inc.
|
|
|
|
|
|
|
|
NVCR / NovoCure Limited
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
DCGO / DocGo Inc.
|
|
|
|
|
|
|
|
STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
PBAX / Phoenix Biotech Acquisition Corp.
|
|
|
|
|
|
|
|
CSTL / Castle Biosciences, Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
TMCI / Treace Medical Concepts, Inc.
|
|
|
|
|
|
|
|
INBX / Inhibrx Biosciences, Inc.
|
|
|
|
|
|
|
|
EQT / EQT Corporation
|
|
|
|
|
|
|
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|